stoxline Quote Chart Rank Option Currency Glossary
  
Haoxi Health Technology Limited (HAO)
1.91  -0.04 (-2.05%)    02-10 05:19
Open: 1.92
High: 2
Volume: 81,634
  
Pre. Close: 1.95
Low: 1.87
Market Cap: 69(M)
Technical analysis
2025-02-07 4:44:45 PM
Short term     
Mid term     
Targets 6-month :  2.93 1-year :  4.67
Resists First :  2.5 Second :  4
Pivot price 1.63
Supports First :  0.09 Second :  0.08
MAs MA(5) :  2.07 MA(20) :  1.26
MA(100) :  0.5 MA(250) :  3.6
MACD MACD :  0.5 Signal :  0.4
%K %D K(14,3) :  48.3 D(3) :  50.7
RSI RSI(14): 60.4
52-week High :  10.6 Low :  0.09
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ HAO ] has closed below upper band by 44.3%. Bollinger Bands are 248.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 9 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.01 - 2.03 2.03 - 2.04
Low: 1.83 - 1.85 1.85 - 1.87
Close: 1.87 - 1.91 1.91 - 1.94
Company Description

Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. It serves advertiser client base primarily in the healthcare industry. The company was founded in 2018 and is based in Beijing, China.

Headline News

Thu, 23 Jan 2025
Haoxi Health Announces 1-for-25 Reverse Stock Split to Take Effect January 27 - StockTitan

Thu, 23 Jan 2025
Haoxi Health Technology Limited Announces 1-for-25 Reverse Share Split - GlobeNewswire

Mon, 06 Jan 2025
Investors Still Aren't Entirely Convinced By Haoxi Health Technology Limited's (NASDAQ:HAO) Earnings Despite 28% Price Jump - Simply Wall St

Wed, 27 Nov 2024
Haoxi Health Technology Limited Awarded a RMB30 Milllion - GlobeNewswire

Wed, 06 Nov 2024
Haoxi Health Technology Limited Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency - Yahoo Finance

Tue, 29 Oct 2024
Haoxi Health Technology Limited Reports Financial Results for Fiscal Year Ended June 30, 2024 - GlobeNewswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Communication Services
Industry:
Advertising Agencies
Shares Out 2 (M)
Shares Float 6 (M)
Held by Insiders 21.7 (%)
Held by Institutions 2.6 (%)
Shares Short 54 (K)
Shares Short P.Month 47 (K)
Stock Financials
EPS 1
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.34
Profit Margin 2.6 %
Operating Margin 3.5 %
Return on Assets (ttm) 10.7 %
Return on Equity (ttm) 20.1 %
Qtrly Rev. Growth 31.2 %
Gross Profit (p.s.) 1.29
Sales Per Share 22.77
EBITDA (p.s.) 0.81
Qtrly Earnings Growth -3.8 %
Operating Cash Flow -1 (M)
Levered Free Cash Flow -4 (M)
Stock Valuations
PE Ratio 1.89
PEG Ratio 0
Price to Book value 5.42
Price to Sales 0.08
Price to Cash Flow -5.42
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android